Non-invasive telemonitoring improves survival and reduces hospitalizations in patients with chronic heart failure. These findings were presented at ESC 2025, highlighting a promising strategy for managing a condition that causes frequent hospital visits and high treatment costs worldwide.

Data from 34 randomized controlled trials involving 16,179 patients were analyzed. Participants received either non-invasive telemonitoring or standard care. The impact on all-cause mortality, heart failure-related hospitalisations, and overall hospitalisations was assessed.

The analysis showed that telemonitoring lowered all-cause mortality by 18% and heart failure-related hospitalizations by 20%, while overall hospitalizations remained unchanged. Older patients, particularly those aged 70 and above, benefited most. Mobile-based telemonitoring demonstrated the greatest reduction in hospitalisations. The intervention also improved patients’ quality of life, self-care behaviours, and adherence to treatment.

These results position non-invasive telemonitoring as a safe and effective approach for chronic heart failure management. Widespread use of mobile platforms, especially in older adults, could enhance patient outcomes. Further work is needed to evaluate long-term adherence, cost-effectiveness, and integration into routine clinical practice.